Relationship between JAK2 V617F point mutation and clinical characteristics of BCR-ABL negative myeloproliferative diseases patients

CLINICAL FOCUS ›› 2008, Vol. 23 ›› Issue (5): 317-0.

Previous Articles Next Articles

Relationship between JAK2 V617F point mutation and clinical characteristics of BCR-ABL negative myeloproliferative diseases patients

WANG Dong-mei;GUO Hui-mei;WANG Jv-mei;SUN Guo-feng;GUO Xiao-ling;PAN Ling

Online:2008-03-05 Published:2008-03-05

Abstract

CLC Number:

R551.31

WANG Dong-mei;GUO Hui-mei;WANG Jv-mei;SUN Guo-feng;GUO Xiao-ling;PAN Ling. Relationship between JAK2 V617F point mutation and clinical characteristics of BCR-ABL negative myeloproliferative diseases patients[J]. CLINICAL FOCUS, 2008, 23(5): 317-0.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2008/V23/I5/317

[1]	. [J]. Clinical Focus, 2012, 27(19): 1731-1733.
[2]	TANG Yuan-yan;LIANG Yan;XIONG Tao;ZHANG Li-ming;YU Yong-zhi;HUANG Zhi-ping. Detection of +8 and 20q- in myelodysplastic syndrome patients by fluorescence in situ hybridization and cytogenetic analysis [J]. Clinical Focus, 2012, 27(9): 761-763.
[3]	. [J]. CLINICAL FOCUS, 2010, 25(7): 592-595.
[4]	. [J]. CLINICAL FOCUS, 2010, 25(4): 364-366.
[5]	. [J]. CLINICAL FOCUS, 2007, 22(14): 1054-1056.

Relationship between JAK2 V617F point mutation and clinical characteristics of BCR-ABL negative myeloproliferative diseases patients

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 5

Recommended Articles

Metrics

Comments